Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.670
-0.090 (-5.11%)
At close: Apr 18, 2024, 4:00 PM
1.720
+0.050 (2.99%)
After-hours: Apr 18, 2024, 7:52 PM EDT
Rallybio Stock Forecast
RLYB's stock price has decreased by -60.97% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Rallybio stock have an average target of 10.42, with a low estimate of 1.50 and a high estimate of 18. The average target predicts an increase of 523.95% from the current stock price of 1.67.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Rallybio stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +379.04% | Apr 18, 2024 |
| Wedbush | Wedbush | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +558.68% | Apr 11, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +379.04% | Mar 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $9 | Strong Buy | Maintains | $12 → $9 | +438.92% | Mar 13, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $16 → $8 | Buy | Maintains | $16 → $8 | +379.04% | Feb 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.60
from -1.84
EPS Next Year
-1.48
from -1.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 194.7M | 649.4M |
| Avg | n/a | n/a | n/a | 65.9M | 233.2M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 886.1% |
| Avg | - | - | - | - | 254.1% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.11 | -0.85 | -0.80 | -1.72 | -1.75 |
| Avg | -1.60 | -1.48 | -1.42 | -1.67 | -1.70 |
| Low | -2.07 | -2.05 | -2.27 | -1.61 | -1.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.